Literature DB >> 35203305

C-C Chemokine Receptor 7 in Cancer.

Colin A Bill1, Christopher M Allen1, Charlotte M Vines1.   

Abstract

C-C chemokine receptor 7 (CCR7) was one of the first two chemokine receptors that were found to be upregulated in breast cancers. Chemokine receptors promote chemotaxis of cells and tissue organization. Since under homeostatic conditions, CCR7 promotes migration of immune cells to lymph nodes, questions immediately arose regarding the ability of CCR7 to direct migration of cancer cells to lymph nodes. The literature since 2000 was examined to determine to what extent the expression of CCR7 in malignant tumors promoted migration to the lymph nodes. The data indicated that in different cancers, CCR7 plays distinct roles in directing cells to lymph nodes, the skin or to the central nervous system. In certain tumors, it may even serve a protective role. Future studies should focus on defining mechanisms that differentially regulate the unfavorable or beneficial role that CCR7 plays in cancer pathophysiology, to be able to improve outcomes in patients who harbor CCR7-positive cancers.

Entities:  

Keywords:  C-C chemokine receptor 7; cancer; metastases; survival

Mesh:

Substances:

Year:  2022        PMID: 35203305      PMCID: PMC8870371          DOI: 10.3390/cells11040656

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  307 in total

1.  Sequence requirements for micro RNA processing and function in human cells.

Authors:  Yan Zeng; Bryan R Cullen
Journal:  RNA       Date:  2003-01       Impact factor: 4.942

Review 2.  Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature.

Authors:  Angus Dalgleish; Peter Featherstone; Viatcheslav Vlassov; Moshe Rogosnitzky
Journal:  Invest New Drugs       Date:  2014-01-18       Impact factor: 3.850

3.  CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation.

Authors:  Stephen Chu-Sung Hu; Chi-Ling Lin; Chien-Hui Hong; Hsin-Su Yu; Gwo-Shing Chen; Chih-Hung Lee
Journal:  J Dermatol Sci       Date:  2013-12-17       Impact factor: 4.563

4.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

5.  CCR7/CCL21 migration on fibronectin is mediated by phospholipase Cgamma1 and ERK1/2 in primary T lymphocytes.

Authors:  Laura A Shannon; Psachal A Calloway; T Paul Welch; Charlotte M Vines
Journal:  J Biol Chem       Date:  2010-10-01       Impact factor: 5.157

Review 6.  CCR7 mediates inflammation-associated tumor progression.

Authors:  Yvonne K Mburu; Jun Wang; Michelle A Wood; William H Walker; Robert L Ferris
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

7.  Overcoming mTOR inhibition-induced paradoxical activation of survival signaling pathways enhances mTOR inhibitors' anticancer efficacy.

Authors:  Xuerong Wang; Natalyn Hawk; Ping Yue; John Kauh; Suresh S Ramalingam; Haian Fu; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Biol Ther       Date:  2008-12-08       Impact factor: 4.742

8.  CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.

Authors:  Sylvia Ganghammer; Evelyn Hutterer; Elisabeth Hinterseer; Gabriele Brachtl; Daniela Asslaber; Peter William Krenn; Tamara Girbl; Petra Berghammer; Roland Geisberger; Alexander Egle; Antonella Zucchetto; Anna Kruschinski; Valter Gattei; Alexandre Chigaev; Richard Greil; Tanja Nicole Hartmann
Journal:  Oncotarget       Date:  2015-05-20

Review 9.  Endothelin receptors and their antagonists.

Authors:  Janet J Maguire; Anthony P Davenport
Journal:  Semin Nephrol       Date:  2015-03       Impact factor: 5.299

Review 10.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

View more
  2 in total

1.  CC chemokine receptor 7 promotes macrophage recruitment and induces M2-polarization through CC chemokine ligand 19&21 in oral squamous cell carcinoma.

Authors:  Wan-Hang Zhou; Yao Wang; Cong Yan; Wei-Dong Du; Maged Ali Al-Aroomi; Li Zheng; Shan-Feng Lin; Jia-Xing Gao; Sheng Jiang; Zeng-Xu Wang; Chang-Fu Sun; Fa-Yu Liu
Journal:  Discov Oncol       Date:  2022-07-29

2.  PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer.

Authors:  Xu Wang; Rui Sun; Shixin Chan; Lei Meng; Yuanmin Xu; Xiaomin Zuo; Zhenglin Wang; Xianyu Hu; Qijun Han; Longfei Dai; Tao Bai; Zhen Yu; Ming Wang; Wenqi Yang; Huabing Zhang; Wei Chen
Journal:  Front Genet       Date:  2022-09-14       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.